[HTML][HTML] The potential of probiotics as ingestible adjuvants and immune modulators for antiviral immunity and management of SARS-CoV-2 infection and COVID-19

S Tomkinson, C Triscott, E Schenk, A Foey - Pathogens, 2023 - mdpi.com
Probiotic bacteria are able to modulate general antiviral responsiveness, including barrier
functionality and innate and adaptive immune responses. The COVID-19 pandemic …

Science's Response to CoVID‐19

MJC Long, Y Aye - ChemMedChem, 2021 - Wiley Online Library
CoVID‐19 is a multi‐symptomatic disease which has made a global impact due to its ability
to spread rapidly, and its relatively high mortality rate. Beyond the heroic efforts to develop …

[HTML][HTML] Beneficial effects of L-Arginine in patients hospitalized for COVID-19: new insights from a randomized clinical trial

V Trimarco, R Izzo, A Lombardi, A Coppola… - Pharmacological …, 2023 - Elsevier
We have recently demonstrated in a double-blind randomized trial the beneficial effects of L-
Arginine in patients hospitalized for COVID-19. We hypothesize that one of the mechanisms …

[HTML][HTML] CXCL8, CCL2, and CMV seropositivity as new prognostic factors for a severe COVID-19 course

E Pius-Sadowska, A Niedźwiedź, P Kulig… - International Journal of …, 2022 - mdpi.com
The exact pathophysiology of severe COVID-19 is not entirely elucidated, but it has been
established that hyperinflammatory responses and cytokine storms play important roles. The …

[HTML][HTML] The good and bad of Nrf2: an update in Cancer and New perspectives in COVID-19

S Emanuele, A Celesia, A D'Anneo… - International Journal of …, 2021 - mdpi.com
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a well-known transcription factor best
recognised as one of the main regulators of the oxidative stress response. Beyond playing a …

[HTML][HTML] Metabolic reprogramming in SARS-CoV-2 infection impacts the outcome of COVID-19 patients

LE Martínez-Gómez, I Ibarra-González… - Frontiers in …, 2022 - frontiersin.org
Introduction Severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) infection
triggers inflammatory clinical stages that affect the outcome of patients with coronavirus …

[HTML][HTML] An overview on the epidemiology and immunology of COVID-19

M Meskini, MR Rami, P Maroofi, S Ghosh… - Journal of Infection and …, 2021 - Elsevier
Coronaviruses are a large family of viruses that cause illnesses ranging from the common
cold to more severe diseases such as Middle East Respiratory Syndrome (MERS), Severe …

[HTML][HTML] SARS-CoV-2, placental histopathology, gravity of infection and immunopathology: is there an association?

L Resta, A Vimercati, G Cazzato, M Fanelli… - Viruses, 2022 - mdpi.com
(1) Background: As the pandemic months progress, more and more evidence shows that the
placenta acts as a “barrier” to SARS-CoV-2, although rare cases of vertical transmission …

[HTML][HTML] Biochanin A as a modulator of the inflammatory response: an updated overview and therapeutic potential

FB Felix, JP Vago, VA Beltrami, JMD Araujo… - Pharmacological …, 2022 - Elsevier
Uncontrolled inflammation and failure to resolve the inflammatory response are crucial
factors involved in the progress of inflammatory diseases. Current therapeutic strategies …

[HTML][HTML] Immune signature of covid-19: In-depth reasons and consequences of the cytokine storm

P Niedźwiedzka-Rystwej, A Majchrzak… - International Journal of …, 2022 - mdpi.com
In the beginning of the third year of the fight against COVID-19, the virus remains at least still
one step ahead in the pandemic “war”. The key reasons are evolving lineages and …